Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
about
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesPrognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.Minimal residual disease detection using flow cytometry: Applications in acute leukemia.Major impact of an early bone marrow checkpoint (day 21) for minimal residual disease in flow cytometry in childhood acute lymphoblastic leukemia.Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia.Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study.Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry.Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders.Issue Highlight 2015.Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using "MRD lite" panel.Flow cytometry analysis of receptor internalization/shedding.
P2860
Q26828511-49BF9316-34ED-4C32-A6F0-6AB6B4CBD85AQ35976588-0300A498-4174-4B94-9FC9-88C8941D0517Q38852472-987747D9-1F19-438C-9809-DC85968C4DE6Q41246402-04029A85-2BB5-4052-844B-25DF126462B7Q41724569-7C637BBC-542B-4ADA-9729-E988EB20476EQ44783681-B2A971B7-2530-4E18-981B-CBDAF23E3DD7Q48096830-BBF20CDE-23E0-4942-B717-4057F238D659Q48762439-E57C2986-0313-4344-BE18-0BDD9E6F5319Q51804210-7BB6ADC6-2A88-4B58-B22A-0506D2055845Q53400845-24DB8B27-27C4-41D6-AD6C-3D2F85664946Q53717785-F4B79AB0-63B8-4E1B-90A3-255D9A4D04C0Q54635907-BEF2B979-38D6-4676-BC9D-FAEA4041A71E
P2860
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Methodological aspects of mini ...... a: A French multicenter study.
@en
Methodological aspects of mini ...... a: A French multicenter study.
@nl
type
label
Methodological aspects of mini ...... a: A French multicenter study.
@en
Methodological aspects of mini ...... a: A French multicenter study.
@nl
prefLabel
Methodological aspects of mini ...... a: A French multicenter study.
@en
Methodological aspects of mini ...... a: A French multicenter study.
@nl
P2093
P2860
P356
P1476
Methodological aspects of mini ...... ia: A French multicenter study
@en
P2093
Adriana Plesa
Andre Baruchel
Chantal Brouzes
Chantal Fossat
Elizabeth Macintyre-Davi
Emilienne Kuhlein
Francine Garnache-Ottou
French Multicenter Study Groups for Pediatric and Adult ALL
Herve Dombret
Isabelle Arnoux
P2860
P356
10.1002/CYTO.B.21195
P577
2014-11-01T00:00:00Z